By the time I sit down at the table to pick at my turkey, I will have invested £1,000 in my looks. I'm going to have to cut ...

Weight-loss drugs are typically not covered by private insurance plans, and in late November, President Joe Biden proposed ...

Novo Nordisk is a bargain stock with tremendous growth potential. Vertex Pharmaceuticals has seven clear paths to growth ...

Patients self-administer the drug using a pre-dosed injector pen, but Lilly recently introduced the product in single-dose ...

BioAge Labs said on Friday it is discontinuing the mid-stage trial of its experimental obesity drug after high levels of certain liver enzymes were observed in some patients, sending its shares down ...

The expansion of a newly acquired facility in Wisconsin is Lilly’s largest U.S. manufacturing investment outside of Indiana ...

Data continue to show that tirzepatide, called Mounjaro for type 2 diabetes and Zepbound for weight loss, is safe and effective, but side effects remain.

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Millions of NHS patients could wait 12 years for weight-loss drug Mounjaro, which rivals Ozempic and Wegovy. Although the ...

Eli Lilly and Company announced a significant expansion at its Pleasant Prairie facility Thursday. The pharmaceutical giant ...

Eli Lilly and Company has announced topline results from the SURMOUNT-5 phase 3b open-label randomized clinical trial.

Eli Lilly said it would invest $3 billion to expand a recently acquired manufacturing facility to meet growing demand for its diabetes and weight-loss medicines.